Pretreatment with lovastatin prevents n-methyl-d-aspartate-induced neurodegeneration in the magnocellular nucleus basalis and behavioral dysfunction

Journal of Alzheimer's Disease

Volumn 17, Issue 2, 2009, Pages 327-336

  Dolga, Amalia M ^a   Granic, Ivica ^a   Nijholt, Ingrid M ^a   Nyakas, Csaba ^a,b   Van Der Zee, Eddy A ^a   Luiten, Paul G M ^a   Eisel, Ulrich L M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cholinergic neurons; Excitotoxicity; Lovastatin; Magnocellular nucleus basalis; NMDA; Passive avoidance test; PKB Akt

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; MEVINOLIN; N METHYL DEXTRO ASPARTIC ACID; PROTEIN KINASE B;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CARDIOVASCULAR EFFECT; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG INHIBITION; EXCITOTOXICITY; MAGNOCELLULAR NUCLEUS; MALE; MEMORY DISORDER; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

EID: 65049087189     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1052     Document Type: Article

References (30)

1. Lu D, Qu C, Goussev A, Jiang H, Schallert T, Mahmood A, Chen J, Li Y, Chopp M (2007) Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J Neurotrauma 24, 1132-1146.
2. Kretz A, Schmeer C, Tausch S, Isenmann S (2006) Simvastatin promotes heat shock protein 27 expression and Akt activation in the rat retina and protects axotomized retinal ganglion cells in vivo. Neurobiol Dis 2, 421-430.
3. Dolga AM, Nijholt IM, Ostroveanu A, Ten Bosch Q, Luiten PGM, Eisel ULM (2008) Lovastatin induces neuroprotection through tumor necrosis factor receptor 2 signaling pathways. J Alzheimers Dis 13, 111-122.
4. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel ULM (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. J Biol Chem 289, 32869-32881.
5. Dunnett SB, Whishaw IQ, Jones GH, Bunch ST (1987) Behavioural, biochemical and histological effects of different neurotoxic aminoacids injected into nucleus basalis magno-cellularis of rats. Neuroscience 20, 653-669.
6. Luiten PGM, Douma BRK, Van der Zee EA, Nyakas C (1995) Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+ antagonist nimodipine, influence of aging and developmental drug treatment. Neurodegeneration 4, 307-314.
7. Luiten PGM, Gaykema RP, Traber J, Spencer DG (1987) Cortical projection pattern of magnocellular basal nucleus subdivisions as revealed by anterogradely transported Phaseolus vulgaris leucoagglutinin. Brain Res 413, 229-250.
8. Stuiver BT, Douma BR, Bakker R, Nyakas C, Luiten PG (1996) In vivo protection againstNMDA-induced neurodegeneration by MK-801 and nimodipine: combined therapy and temporal course of protection. Neurodegeneration 5, 153-159.
9. Harkany T, Mulder J, Sasvari M, Abraham I, Konya C, Zarandi M, Penke B, Luiten PGM, Nyakas C (1999) N-Methyl-D- aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against β-amyloid neurotoxicity. Neurobiol Dis 6, 109-121.
10. Bartus RT, Dean RL 3rd, Beer B, Lippa AS (1982) The cholin- ergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
11. Van der Zee EA, Douma BR, Bohus B, Luiten PG (1994) Passive avoidance training induces enhanced levels of immunore-activity for muscarinic acetylcholine receptor and coexpressed PKC gamma and MAP-2 in rat cortical neurons. Cereb Cortex 4, 376-390.
12. Balduini W, Mazzoni E, Carloni S, De Simoni MG, Perego C, Sironi L, Cimino M (2003) Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke 34, 2007-2012
13. Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, Cannon TD, Silva JA (2005) The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurof ibromatosis type 1. Curr Biol 15, 1961-1967.
14. Li L, Cao D, Kim H, Lester R, Fukuchi K (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol 60, 729-739.
15. Franklin KJB, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego.
16. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95, 8880-8885.
17. Gaykema RP, Luiten PG, Nyakas C, Traber J (1990) Cortical projection patterns of the medial septum-diagonal band complex. J CompNeurol 293, 103-124.
18. Gaykema RPA, Compaan J, Nyakas C, Horvarth E, Luiten PGM (1989), Long-term effects of cholinergic basal forebrain lesions on neuropeptide Y and somatostatin immunoreactivity in rat neocortex. Brain Res 489, 392-396.
19. Harkany T, Dijkstra IM, Oosterink J, Horvath KM, Abraham I, Keijser J, Van der Zee EA, Luiten PGM (2000) Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine. Neuroscience 101, 101-114.
20. Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, di Polo A (2002) TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 22, 3977-3986.
21. Dudchenko PA (2004) An overview of the tasks used to test working memory in rodents. Neurosci Biobehav Rev 28, 699-709.
22. Senechal Y, Kelly PH, Dev KK (2008) Amyloid precursor protein knockout mice show age dependend deficits in passive avoidance learning. Behav Brain Res 186, 126-132.
23. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizen-maier K, Eisel U (2002) Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 22, RC216: 1-7.
24. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z, Gala R, Simon RP (2008) In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: is chemic postconditioning. JCereb Blood Flow Metab 28, 232-241.
25. Prinz V, Laufs U, Gertz K, Kronenberg G, Balkaya M, Leithner C, Lindauer U, Endres M (2008) Intravenous rosuvastatin for acute stroke treatment: an animal study. Stroke 39, 433-438.
26. Duncan JS, Litchfield DW (2008) Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim Biophys Acta 1784, 33-47.
27. Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fehner T, Schubert-Zsilavecz M, Karas M, Muller WE, Wood WG (2005) Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther 312, 786-793.
28. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275, 10761-10766.
29. Kotti TJ, Ramirez DM, Pfeiffer BE, Huber KM, Russell DW (2006) Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci USA103, 3869-3874.
30. Wolozin B (2004) Cholesterol, statins and dementia. Curr Opin Lipidol 15, 667-672.